Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using theemail support widget if the problem persists.
Be the First to Know and Act on Market Moving News.
In a significant move within the pharmaceutical industry, Arvinas Inc. (NASDAQ: ARVN) announced on Wednesday a comprehensive agreement with Novartis (LON:0QLR) (SIX:NOVN)...
BOSTON - Pyxis Oncology, Inc. (NASDAQ: PYXS), a clinical-stage biopharmaceutical company, announced the sale of its royalty rights for Beovu® and another asset to Novartis...